Fricke, StephanStephanFrickeBraun, ArminArminBraunBlaudszun, André-RenéAndré-RenéBlaudszunSack, UlrichUlrichSack2024-04-262024-04-262022-02-23https://publica.fraunhofer.de/handle/publica/466968The present invention relates to a binding molecule specifically binding to human CD4 for use in the prevention, amelioration and/or treatment of at least symptom of a disease associated with inflammation of the respiratory tract and/or immunologically induced injury of the respiratory tract in a human subject, wherein the binding molecule is administered intranasally and/or via inhalation and/or systemically, as well as to pharmaceutical compositions, pulmonary drug delivery kits and pharmaceutical packages related thereto.enpatentEP3957364 A1EP20200191900